GSA Capital Partners’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Sell |
306,487
-302,169
| -50% | -$363K | 0.03% | 1133 |
|
|
2025
Q1 | $657K | Buy |
608,656
+478,922
| +369% | +$517K | 0.06% | 608 |
|
|
2024
Q4 | $227K | Buy |
+129,734
| New | +$227K | 0.02% | 1354 |
|
|
2022
Q1 | – | Sell |
-101,494
| Closed | -$398K | – | 1632 |
|
|
2021
Q4 | $398K | Buy |
101,494
+57,589
| +131% | +$226K | 0.05% | 748 |
|
|
2021
Q3 | $289K | Buy |
+43,905
| New | +$289K | 0.03% | 1045 |
|
|
2021
Q2 | – | Sell |
-105,852
| Closed | -$478K | – | 1473 |
|
|
2021
Q1 | $478K | Buy |
105,852
+63,908
| +152% | +$289K | 0.08% | 379 |
|
|
2020
Q4 | $252K | Sell |
41,944
-40,959
| -49% | -$246K | 0.04% | 842 |
|
|
2020
Q3 | $616K | Buy |
+82,903
| New | +$616K | 0.1% | 283 |
|
|
2019
Q2 | – | Sell |
-61,910
| Closed | -$823K | – | 1593 |
|
|
2019
Q1 | $823K | Buy |
+61,910
| New | +$823K | 0.08% | 392 |
|
|
2014
Q1 | – | Sell |
-7,020
| Closed | -$269K | – | 1690 |
|
|
2013
Q4 | $269K | Buy |
+7,020
| New | +$269K | 0.02% | 1277 |
|